Showing results (761-770 of 815) with videos related to
Sort By:
Pageof 82
Nanomaterials (Basel, Switzerland)|March 11, 2023
Synthesis and Functional Characterization of Co<sub>x</sub>Fe<sub>3-x</sub>O<sub>4</sub>-BaTiO<sub>3</sub> Magnetoelectric Nanocomposites for Biomedical ApplicationsTimur R Nizamov, Abdulkarim A Amirov, Tatiana O Kuznetsova, et al.Acta Naturae|January 25, 2023
Multiple Sclerosis Is Associated with Immunoglobulin Germline Gene Variation of Transitional B CellsY A Lomakin, L A Ovchinnikova, M N Zakharova, et al.Gigiena I Sanitariia|February 13, 2018
[The importance of sanitary microbiological indices in the evaluation of epidemiological safety of water use in conditions of chemical contamination of water]Yu A Rakhmanin, L V Ivanova, T Z Artemova, et al.Terapevticheskii Arkhiv|January 29, 2008
[Season and age related structure of acute intestinal infections morbidity in the Russian Federation]A T Podkolzin, E B Fenske, N Iu Abramycheva, et al.Parazitologiia|August 30, 2008
[Detection of the West Nile Virus and its genetic typing in ixodid ticks (Parasitiformes: Ixodidae) in Tomsk City and its suburbs]N S Moskvitina, V N Romanenko, V A Ternovoĭ, et al.Frontiers in Immunology|October 8, 2025
CD8<sup>+</sup> T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumorsRoman V Uzhachenko, Salvador González Ochoa, Thanigaivelan Kanagasabai, et al.The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.Cancer Research Communications|August 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung CancerTakahiko Murayama, Navin R Mahadevan, Catherine B Meador, et al.Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Changli Qian, Erica Holdridge, et al.Pageof 82